Ravi Rajmohan, Zeinah Al‐Darsani, Chu‐Ching Ho, Joey Wong, Annlia Paganini‐Hill, Thomas Montine, Maria Corrada, Claudia Kawas
{"title":"Vascular risk factors and cerebrovascular pathologic changes on autopsy: The 90+ Study","authors":"Ravi Rajmohan, Zeinah Al‐Darsani, Chu‐Ching Ho, Joey Wong, Annlia Paganini‐Hill, Thomas Montine, Maria Corrada, Claudia Kawas","doi":"10.1002/alz.14454","DOIUrl":null,"url":null,"abstract":"INTRODUCTIONCerebrovascular pathologic changes (CVPC) are prevalent and associated with dementia in those ≥ 90 years. However, CVPC associations to traditional risk factors (hypertension, diabetes, and hyperlipidemia) are variable. We hypothesized that neither traditional risk factors nor related medications would be associated with CVPC presence.METHODSIn autopsy volunteers from <jats:italic>The 90+ Study</jats:italic>, odds ratios (OR) of CVPC presence to self‐reported vascular risk factors and cardiovascular medication classes were calculated using logistic regressions adjusted for age of death, sex, and education.RESULTSIn 267 participants (mean age at death 98 (±3.5) years; 75% female), CVPC presence was not related to traditional risk factors. Lower odds of atherosclerosis with diuretics [OR 0.55] and lower odds of cerebral amyloid angiopathy (CAA) with B‐blocker [OR 0.57] or vasodilator [OR 0.40] use were observed.DISCUSSIONOur findings suggest that vascular risk factors are not risk factors for CVPC at this age, medications have mitigated risks, or survival bias obscures associations.Highlights<jats:list list-type=\"bullet\"> <jats:list-item>Cardiovascular risk factors are thought to contribute to cerebrovascular diseases.</jats:list-item> <jats:list-item>Risk factors were generally not associated with cerebrovascular changes.</jats:list-item> <jats:list-item>Lower odds of certain cerebrovascular changes were associated with antihypertensive use.</jats:list-item> </jats:list>","PeriodicalId":7471,"journal":{"name":"Alzheimer's & Dementia","volume":"35 1","pages":""},"PeriodicalIF":13.0000,"publicationDate":"2025-01-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Alzheimer's & Dementia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1002/alz.14454","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
INTRODUCTIONCerebrovascular pathologic changes (CVPC) are prevalent and associated with dementia in those ≥ 90 years. However, CVPC associations to traditional risk factors (hypertension, diabetes, and hyperlipidemia) are variable. We hypothesized that neither traditional risk factors nor related medications would be associated with CVPC presence.METHODSIn autopsy volunteers from The 90+ Study, odds ratios (OR) of CVPC presence to self‐reported vascular risk factors and cardiovascular medication classes were calculated using logistic regressions adjusted for age of death, sex, and education.RESULTSIn 267 participants (mean age at death 98 (±3.5) years; 75% female), CVPC presence was not related to traditional risk factors. Lower odds of atherosclerosis with diuretics [OR 0.55] and lower odds of cerebral amyloid angiopathy (CAA) with B‐blocker [OR 0.57] or vasodilator [OR 0.40] use were observed.DISCUSSIONOur findings suggest that vascular risk factors are not risk factors for CVPC at this age, medications have mitigated risks, or survival bias obscures associations.HighlightsCardiovascular risk factors are thought to contribute to cerebrovascular diseases.Risk factors were generally not associated with cerebrovascular changes.Lower odds of certain cerebrovascular changes were associated with antihypertensive use.
期刊介绍:
Alzheimer's & Dementia is a peer-reviewed journal that aims to bridge knowledge gaps in dementia research by covering the entire spectrum, from basic science to clinical trials to social and behavioral investigations. It provides a platform for rapid communication of new findings and ideas, optimal translation of research into practical applications, increasing knowledge across diverse disciplines for early detection, diagnosis, and intervention, and identifying promising new research directions. In July 2008, Alzheimer's & Dementia was accepted for indexing by MEDLINE, recognizing its scientific merit and contribution to Alzheimer's research.